|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/513 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3518932 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17823017.3 |
| Date of filing the European patent application | 2017-09-29 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2024-11-13 |
| (46) | Date of publication of the claims translation | 2025-02-10 |
| (86) | Number | PCT/EP2017/074849 |
| Date | 2017-09-29 |
| (87) | Number | WO 2018/060463 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662402150 P | 2016-09-30 | US | |
| 201662402004 P | 2016-09-30 | US |
| (72) |
RAJASEKHAR, Vijaykumar Reddy , US
JOHNSON, Brendan Mark , US
MACLEAN, David B. , US
SEELY, Lynn , US
MUDD, Paul, N. , US
FAESSEL, Hélène M. , US
|
| (73) |
Sumitomo Pharma Switzerland GmbH ,
Aeschengraben 27
Floor 22, 4051 Basel,
CH
Takeda Pharmaceutical Company Limited , 1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prostatos vėžio gydymas |
| TREATMENT OF PROSTATE CANCER |